Differin Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Differin, and what generic alternatives are available?
Differin is a drug marketed by Galderma Labs Lp and is included in five NDAs. There are five patents protecting this drug and one Paragraph IV challenge.
This drug has fifty-six patent family members in twenty-two countries.
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the adapalene profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Differin
A generic version of Differin was approved as adapalene by P AND L on June 2nd, 2010.
Summary for Differin
International Patents: | 56 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 22 |
Patent Applications: | 4,663 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for Differin |
Drug Sales Revenues: | Drug sales revenues for Differin |
What excipients (inactive ingredients) are in Differin? | Differin excipients list |
DailyMed Link: | Differin at DailyMed |
Recent Clinical Trials for Differin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wake Forest University Health Sciences | Early Phase 1 |
Bausch Health Americas, Inc. | Early Phase 1 |
Aurobindo Pharma Ltd | Phase 3 |
Pharmacology for Differin
Drug Class | Retinoid |
Anatomical Therapeutic Chemical (ATC) Classes for Differin
US Patents and Regulatory Information for Differin
Differin is protected by five US patents.
Patents protecting Differin
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF ACNE VULGARIS
Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACNE
Expired US Patents for Differin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | DIFFERIN | adapalene | SOLUTION;TOPICAL | 020338-001 | May 31, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | CREAM;TOPICAL | 020748-001 | May 26, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | SOLUTION;TOPICAL | 020338-001 | May 31, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | CREAM;TOPICAL | 020748-001 | May 26, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Galderma Labs Lp | DIFFERIN | adapalene | GEL;TOPICAL | 021753-001 | Jun 19, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Differin
See the table below for patents covering Differin around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 60325379 | ⤷ Try a Trial | |
Luxembourg | 85849 | ⤷ Try a Trial | |
Australia | 2003216898 | USE OF ADAPALENE FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | ⤷ Try a Trial |
Israel | 78463 | 6-PHENYL-2-NAPHTHALENE DERIVATIVES,THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC PREPARATIONS CONTAINING THEM | ⤷ Try a Trial |
Australia | 2006290364 | Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof | ⤷ Try a Trial |
Cyprus | 1109307 | ⤷ Try a Trial | |
France | 2890861 | COMPOSITIONS COMPRENANT AU MOINS UN DERIVE DE L'ACIDE NAPHTOIQUE ET AU MOINS UN COMPOSE DE TYPE POLYMERES DE POLYURETHANES OU DES DERIVES DE CELUI-CI, LEURS PROCEDE DE PREPARATION, ET LEUR UTILISATION (Composition, useful to treat and/or prevent e.g. dermatological diseases, acne necrotic, acne neonatorum, comprises naphthoic acid derivative and polyurethane type polymer) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for Differin
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1458369 | SPC/GB10/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
1458369 | 08C0024 | France | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218 |
1458369 | 132008901685368 | Italy | ⤷ Try a Trial | PRODUCT NAME: ADAPALENE E BENZOILE PEROSSIDO(EPIDUO); AUTHORISATION NUMBER(S) AND DATE(S): 40440, 20071218;DA 038261018/M A 038261057/M, 20080618 |
0199636 | 300209 | Netherlands | ⤷ Try a Trial | 300209, 20060411, EXPIRES: 20070702 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |